Leg Lengthening With a Motorized Nail in Adolescents: An Alternative to External Fixators? by Krieg, Andreas et al.
ORIGINAL ARTICLE
Leg Lengthening With a Motorized Nail in Adolescents
An Alternative to External Fixators?
Andreas H. Krieg MD, Bernhard M. Speth MD,
Bruce K. Foster MBBS, MD
Received: 27 September 2006 / Accepted: 9 October 2007
 The Association of Bone and Joint Surgeons 2008
Abstract Leg lengthening by external fixation is associ-
ated with various difficulties. We evaluated eight
adolescent patients who underwent leg lengthening with a
motorized intramedullary lengthening device. We asked
whether this method could reduce the time of hospitaliza-
tion and rehabilitation and whether the incidence of
complications commonly associated with external fixators
could be reduced. We compared our preliminary results
with those from other reports, with a focus on leg length
achieved, time of rehabilitation, and rate of complications.
The average leg-length discrepancy was 3.8 cm (range, 3–
5 cm). The average lengthening distance was 3.8 cm
(range, 2.9–4.7 cm). In six patients, leg lengthening was
combined with successful correction of the mechanical axis
alignment. The consolidation index averaged 26 days/cm
(range, 19–41 days/cm). The average hospital stay was
9.6 days. No bone or soft tissue infections were observed.
In comparison to other studies (1.0–2.8 complications/
patient), our results suggest that the difficulties commonly
associated with external fixators can be reduced with this
method. It also allows good angular correction in patients
with mechanical axis deviation. These features combined
with a short time of hospitalization and rehabilitation make
it a promising procedure for limb lengthening.
Level of Evidence: Level IV Therapeutic study. See the
Guidelines for Authors for a complete description of levels
of evidence.
Introduction
Leg lengthening by external fixation is associated with
various complications ranging from 1.0 to 2.8 per patient
[10, 13, 28, 30, 31, 38]. Transfixation of soft tissue by pins
or wires is intrinsic to the method and thus difficulties such
as pain [14, 30, 41] and pin tract or deep infections [10, 30]
are commonly encountered. Muscle contractures and joint
stiffness are additional complications associated with this
method [22, 30]. In cases in which callus distraction is
combined with axis correction, secondary axial deformity
[30, 38] and fractures of the newly formed bone [11, 30,
35] might occur. Restriction in joint mobility [22] and
therefore increased disability accompany the long periods
of treatment, which delay rehabilitation and return to nor-
mal daily activities.
In the past, several approaches were developed to deal
with these problems [2, 7–9, 16–19, 31, 33, 39, 40]. In
1956, Bost and Larsen [8] described femoral lengthen-
ing using a combination of an external fixator for
distraction and an intramedullary nail for stabilization. Leg
lengthening with a temporary external fixator over an
intramedullary nail reduced the time of external fixation
and risk of pin tract infection by almost ½ [31, 33]. The
time of external fixation and the number of pins transfixing
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the skin were believed responsible for these beneficial
effects [31, 33]. Reducing the time of external fixation
accelerates the return to a normal range of motion and
reduces the risk of bone refractures [31]. The risk of pin
tract infections and hence the risk for secondary osteo-
myelitis continue to be problems in methods using external
fixators [29, 35].
Therefore, several groups [2, 16, 39] explored a purely
intramedullary solution for leg lengthening in the 1970s.
The disadvantage of these systems was the use of an
external component connected with the intramedullary nail
with a persisting risk for direct intramedullary infection [2,
16]. After use in two patients, another promising system
[39, 40] managed by radio control later was abandoned
because of insurmountable problems with the energy
supply.
After these initial steps in intramedullary lengthening, at
least three kinds of fully implantable devices [7, 9, 18]
were designed during the last 20 years to solve these
problems. Two of these systems are mechanically activated
lengthening devices [9, 17–19, 21]. Betz et al. [7] devel-
oped the first fully implantable, motorized lengthening
device with a subcutaneous receiver. In 1997, Baumgart
et al. reported successful implantation and outcomes with
no major complications in 12 adult patients for limb
lengthening and bone transport [3]. Nonetheless, results in
the literature are limited and require confirmation.
We therefore posed the following questions: (1) Does
the use of a fully implantable, motorized intramedullary
nail system accomplish therapeutic aims in terms of plan-
ned length achieved, correct mechanical axis alignment,
and functional outcome?; (2) Does the use of a fully
implantable, motorized intramedullary nail reduce the time
of hospitalization and rehabilitation measured by the time
of consolidation and time to full weightbearing?; And (3)
can the incidence of complications commonly associated
with external fixators be reduced with this method?
Materials and Methods
Between August 2003 and May 2005, we prospectively
enrolled eight patients (six males and two females) with an
average age of 15.7 years (range, 13–18 years). These
patients underwent leg lengthening with a fully implant-
able, motorized intramedullary nail system (FITBONE1
Telescope Active Actuator nail [TAA]; WITTENSTEIN
intens1 GmbH, Igersheim, Germany) (Fig. 1) introduced
by Baumgart et al. [4–6]. Patients were selected according
to the following criteria. We included patients with a
maximum age of 18 years with a minimum leg-length
discrepancy of 3 cm who were able to understand and
handle the system. We excluded patients with a history of
deep infection or osteomyelitis within the last 2 years,
patients with insufficient stability of the joints adjacent to
the bone to be lengthened, and patients with an extension
deficit of the knee or pes equinus.
Before surgery, we (AHK, BKF) measured leg-length
discrepancy, preoperative alignment of the mechanical
axis, and joint orientation on plain radiographs. These
measurements were made under conditions based on the
preoperative standard protocol for retrograde corrective
planning described by Baumgart et al. [4, 6]. Different
from conventional trauma nails, the femoral FITBONE1
TAA is straight, which must be considered in preoperative
planning. To achieve a correct mechanical axis and there-
fore avoid early arthritis after limb and joint malalignment,
it is essential to perform supracondylar femoral or proximal
tibial displacement and/or angulation osteotomies at the
time of insertion.
The preoperative level of difficulty was assessed
according to a scale for femoral lengthening with external
fixators devised by Paley et al. [31]. A total score is
derived from this scale, which is based on 12 parameters
that influence risk and difficulty of the individual length-
ening procedure. In patients with correction of the tibia, we
(AHK) used a modified version of the classification
described by Paley et al. (Table 1). The preoperative level
of difficulty in our patients was an average of 6.6 points
(range, 3–10 points).
The nails were implanted into six femurs and two tibias.
The average leg-length discrepancy was 3.8 cm (range, 3–
5 cm). Five femurs and one tibia had a valgus deformity
resulting in an average mechanical axis deviation of
+ 22 mm (range, 10–35 mm). One of the femurs (Fig. 2)
had a translation of one bone diameter (Fig. 2A–C). The
Fig. 1 A FITBONE1 TAA with control and transmitter unit is
shown. (Reproduced with permission of WITTENSTEIN intens1
GmbH, Igersheim, Germany.)
190 Krieg et al. Clinical Orthopaedics and Related Research
123
deformities and leg-length discrepancies were caused by
congenital disease in four patients and by infection in two
patients and were secondary to trauma in two patients. The
minimum followup was 18 months (mean, 33.5 months;
range, 18–36 months) (Table 2). We had prior approval of
the Women’s and Children’s Hospital Ethics Committee;
informed consent for participation in the study was
obtained from all patients.
For lengthening, we used the FITBONE1 TAA, a fully
implantable, motorized intramedullary nail that is avail-
able in various sizes and different designs for the femur
and the tibia [6, 37]. The femoral nail is a straight
stainless steel nail with a maximum distraction length of
40 to 80 mm. The tibial version of the TAA is available
as a straight nail or with the typical proximal Herzog
angulation of tibia nails. In its proximal part, the nails
contain a motor that, through a thin flexible wire, is
connected to a subcutaneous reception antenna. High-
frequency electric energy induced by an external trans-
mitter through the skin is the power source for the motor.
The patient places the transmission antenna on the skin
directly over the palpable reception antenna. The impulses
are triggered manually at the external unit. The motor
delivers the torque that, through a gear and spindle
mechanism, is transformed into a unidirectional, axial
movement. The sound of the motor can be controlled
simultaneously with the help of a stethoscope. This gives
important feedback regarding motor function and motor
load. The daily distraction is modifiable on each use
depending on callus formation. In our patients, we started
distraction with three sessions per day producing a dis-
traction rate of 1 mm per day. At this time, the device is
available only to centers certified by the manufacturer.
During surgery, we (AHK, BKF) controlled rotational
alignment by two parallel 3.0-mm Kirschner wires in the
proximal and distal segments. The osteotomy was made
using a drill-hole corticotomy technique. Mechanical axis
and joint alignment in the frontal plane were maintained or
adjusted with the help of radiolucent rulers attached to the
operating table. Straight reamers were used to enlarge the
medullary canal to 0.5 mm larger than the nail’s diaphyseal
diameter. This allows easy insertion of the nail without
Table 1. Classification scale for the level of difficulty of the tibial lengthening procedure;y
Parameter 0 Points 1 Point 2 Points 3 Points
Planned tibial lengthening (each cm of lengthening = 1 point)
Age (years) 5–19 20–29 30–50 [ 50
Complexity of correction of
deformity at level of
lengthening
None Angulation [ 5\ 20,
rotation [ 10\ 30,
translation \ 50% of
bone diameter or
MAD 1–3 cm
Angulation [ 20,
rotation [ 30,
translation ‡ 50% of bone
diameter or MAD [ 3 cm
Combination of deformities at one
level or multilevel deformities
Other levels of treatment in
same bone
None One additional level
mild complexity
One additional level moderate
complexity
One additional level of severe
complexity or ‡ 2 levels
Associated femoral
lengthening (cm)
None 1–3 3.1–6 [ 6
Stability of joint
(ankle + knee)
None Grade I Grade II Grade III
Fixed plantar flexion
deformity of the ankle
(degrees)
0 1–5 5–15 [ 15
Plantar flexion of the ankle
(degrees)
[ 30 20–30 10–19 \ 10
Osteoarthrosis of the joints None Marginal osteophytes,
subchondral sclerosis
Narrowing of joint space Loss of joint space
Quality of bone Normal Ollier’s disease, mild
osteoporosis,
nonunion
Radiation neurofibromatosis,
osteogenesis imperfecta
Osteonecrosis, infection
Quality of soft tissue Normal Spastic, obese muscular Fibrotic, postradiation, small
open wound
Tissue necrosis, infection, large
open wound
Medical problems and
medication
None Smoking, hypertension,
rheumatoid arthritis,
or other systemic
arthritis
Diabetes, hemophilia, sickle
cell anemia, mild
immunosuppression, bone-
inhibiting medications
Moderate immunosuppression,
antimetabolic chemotherapy
* Modification of the Paley et al. [31] classification for femoral lengthening; mild = 0–6 points, moderate = 7–11 points, severe = ‡ 12 points;
MAD = mechanical axis deviation.
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force and avoids bending moments that could interfere with
the function of the device or alter the desired alignment.
The subcutaneous reception antenna subsequently was
connected with the motor in the proximal part of the nail
through an insulated, thin flexible wire. In the femur, the
wire is placed through a drill hole in the lateral side of the
cortex to avoid an intraarticular position.
Postoperatively, we used the categorical outcome scor-
ing system devised by Paley et al. [31] which they used for
lengthening with external fixators over an intramedullary
nail at the femur. We modified this scoring system for
patients with tibia correction (Table 3) by exchanging the
femur angles with reference tibia angles [31]. At clinical
appointments every week during distraction and after 3, 6,
9, 12, and 18 months, we (AHK, BKF) recorded the use of
analgesics; range of motion of the hip, knee, and ankle; and
any problems or complications.
Radiographs in anteroposterior and lateral views were
taken once per week during the distraction phase and every
4 weeks during the consolidation phase. At the end of the
distraction phase, achieved leg length, postoperative
alignment of the mechanical axis, and joint orientation
were measured on plain radiographs (Fig. 2F–G). The
distraction index was calculated as time of distraction per
Fig. 2A–K (A) Anteroposterior and (B) lateral radiographs are
shown of a 17-year-old boy who sustained a supracondylar
displaced femur fracture after nonoperative treatment in Africa.
(C) He had a leg-length discrepancy of –5 cm. (D) Postoperative
anteroposterior and (E) lateral radiographs show a FITBONE1 13
TAA nail with the subcutaneous antenna. (F) Anteroposterior and
(G) lateral radiographs were obtained after a distraction phase of
49 days; lengthening of 47 mm was achieved. Three months
postoperatively, (H) anteroposterior and (I) lateral radiographs show
good callus formation and the patient started full weightbearing. He
achieved full range of motion in the knee. Two years postopera-
tively, after removal of the implant, (J) anteroposterior and (K)
lateral radiographs show the pelvis was equal and the patient had an
excellent functional outcome.
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millimeters distraction gap (days/mm). Consolidation was
defined when the distraction gap was corticalized on three
of four sides as seen on anteroposterior and lateral radio-
graphs and the patient started full weightbearing without
crutches (Fig. 2H–I). The consolidation index was calcu-
lated as the time to consolidation per centimeter of
distraction gap (days/cm).
Results
Six of eight patients achieved successful bone lengthening
in terms of achieved leg length and postoperative align-
ment of the mechanical axis. Two patients (Patients 3 and
5) were excluded from consolidation and distraction
analysis because of device failure in one and nail breakage
in the other.
The average lengthening distance was 38.1 mm (range,
29–47 mm). Planned length was achieved to an average of
93% (range, 83%–100%). The average distraction period
was 40.3 days (range, 30–50 days) with a distraction index
of 1.1 mm per day (range, 0.9–1.2 mm). In patients in
whom lengthening was combined with corrective osteot-
omy (n = 6), improvement of the mechanical axis
deviation was obtained from preoperatively + 22 mm
(range, 10–35 mm) to postoperatively + 5 mm (range,
0–10 mm). The average correction distance from valgus
to normal mechanical axis deviation was 18 mm (range,
5–32 mm).
Three patients achieved excellent outcome scores, four
had a good score, and one had a fair score. The average
functional outcome score was 80 points. Preoperative knee
function was restored and even showed improvement in
one case. Only during the distraction phase was knee
flexion reduced to an average of 70 (± 20). At the latest
followup, no extension deficit was observed in any of the
patients. There was no reduction in hip function. The
lengthening nail had been removed in all patients after an
average of 20 months.
The average hospital stay was 9.6 days (range, 5–
14 days). Full weightbearing was resumed between 2.5
and 4 months depending on the length of the distraction
period. Radiographic consolidation was observed 94 days
(range, 70–120 days) postoperatively on average. The
average consolidation index was 26 days/cm (range, 19–
41 days/cm). The average consolidation of the five femur
lengthenings was 88 days (range, 70–96 days).
We identified no intraoperative problems or complica-
tions. No bone or soft tissue infection was observed. No
wound healing problems were observed. After the acute
postoperative phase, five patients were completely pain-
free. Three patients experienced discomfort, which in one
was caused by locking bolts and in the other by theT
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antenna. Neither of the two patients required any specific
pain medication. Neither reported any problems after
regular removal of the nail with the antenna 2 years post-
operatively (Fig. J–K). The third patient with the failed
device developed a complex regional pain syndrome. After
removal of all metal, this patient reported mild pain at the
latest followup (36 months).
We encountered two obstacles resolved by additional
surgery. After an antegrade implantation of a FITBONE1
TAA 12/10 in a femur, the nail jammed after 28 days with
a distraction gap of 25 mm. After manipulation, the nail
rejammed at a distraction gap of 27 mm. This patient went
back to full weightbearing 13 weeks after surgery and had
an unprotected fall, which resulted in nail breakage. We
removed the nail and stabilized the femur with an AO
trauma nail maintaining the distraction gap of 24 mm.
Four months after the revision, the patient resumed a
normal life with full mobility. Leg-length discrepancy
remained at 1.2 cm. In another patient, we observed
antenna cable breakage 12 months after implantation at
the femur. We arthroscopically removed the subcutaneous
antenna and the broken cable. All patients were satisfied
with the comfort and ease of handling with this new
system.
Discussion
Callus distraction by intramedullary lengthening has
become an alternative treatment method for limb length-
ening during the last 5 years [4, 6, 9, 14, 19, 21, 27, 37].
Few data have been published concerning the FITBONE1
TAA for intramedullary leg lengthening [4, 6, 37]. The
concept that led to the development of techniques using
intramedullary nails for callus distraction was to achieve
leg lengthening with faster rehabilitation and a lower rate
of complications [3, 9, 19]. We explored whether func-
tionality and outcome support these concepts.
This ongoing study is limited by the small number of
selected patients treated with this method. The results
might be biased by the fact that patients were selected for
this procedure. The complexity and the novelty of this
method afforded selection according to the criteria
described in the Materials and Methods. Also, we lacked
matched control subjects who were treated with external
fixators. The fact that the maximum distraction length was
45 mm in our study also might have positively influenced
our results. In consideration of these limitations, conclu-
sions from the current study can be seen as a general trend.
The use of external fixators is associated with a high rate
of severe complications between 24% and 117% [1, 10, 12,
13, 28, 30, 31, 38]. Combinations of intramedullary nails
and external fixators also show a high rate of complications
in adults [15, 25, 26, 31, 35]. A lower complication rate of
11% was reported in children [34].
The occurrence of complications is not limited to the
time a fixator is attached. Even after removal, additional
complications such as malalignment and refractures often
occur [31, 36, 38].
The complication rate of external fixators in adults
seems to depend on three main factors: the length of dis-
traction, the number of pins, and the age of the patient [1,
10, 13, 28, 30, 31, 38]. In children, length of distraction
seemed to have little effect on the consolidation index,
whereas an increase of angular corrections greater than 30
was related to poor consolidation index [12].
The Albizzia1 nail (DePuy, Villeurbanne, France), the
ISKD1 (Orthofix Inc, Valley, Germany), and the FIT-
BONE1 TAA and Slide Active Actuator (SAA) nails are
the only intramedullary lengthening devices currently used
for limb lengthening [3–5, 14, 19–21, 27, 35, 37]. An
important difference between the FITBONE1 nails and the
other two devices is their motorized mechanism. The
ISKD1 and Albizzia1 nails are mechanical devices. In the
Albizzia1 nail, the required rotations for lengthening have
caused pain and discomfort [19]. Numerous patients with
Albizzia1 nails (22%–39%) were readmitted to the hos-
pital, and rotations of the nail under general or epidural
anesthesia were necessary at some stage of the lengthening
because of the severe pain and discomfort the extensive
rotations had caused at the osteotomy site [14, 19]. The
complication rate after treatment with the Albizzia1 nail
ranges from 22% to 29% if the need for general anesthesia
for distraction is not considered [14, 19]. In 27% of the
patients with implanted ISKD1 nails, mobilization under
general anesthesia was required during the distraction
phase [27]. Complications of 11% to 47% were reported
with the ISKD1 [9, 27].
A complication rate of 13% was described in a larger
number of patients (n = 150) using the FITBONE1 SAA
and TAA nails [6]. In that series, none of the patients
experienced infections and only 3% of the patients had the
nail exchanged. The motorized FITBONE1 TAA does not
require any external manipulation or patient activity, which
increases the patient’s comfort. At the time of discharge of
our patients, seven of eight were pain-free and did not
require any pain medication. During followup, two of those
patients experienced mild irritations, which disappeared
after removal of the system.
At the end of the lengthening, the mechanical axis and
joint alignment must be correct to avoid early arthritis.
In contrast to external fixators, elongation with the
FITBONE1 TAA is performed along the anatomic axis.
The position of the nail after the operation defines the
final alignment after lengthening. Axis adjustments dur-
ing distraction are still possible with the external fixator.
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This is not possible with an intramedullary lengthening
nail.
Retrograde planning [3, 4, 6] takes the preoperative,
postoperative, and postlengthening states into consider-
ation. In cases with mechanical axis deviation and/or joint
malalignment, intraoperative corrections in the form of
bone displacement and/or angulatory corrections may be
required (Fig. 2D–E). In our series, the mechanical axis
deviation was corrected from 22 mm preoperatively to
5 mm postoperatively.
Intramedullary lengthening devices showed a reamed
intramedullary nail does not disturb bone formation in a
distraction gap. Ilizarov emphasized the importance of
preserving the endosteal blood supply in distraction
osteogenesis with an external fixator for better bone heal-
ing [23, 24]. Donnan et al. [12] reported an average
consolidation index of 43.6 days/cm in children with
external fixators. Baumgart et al. [3] observed a consoli-
dation index of 42 days/cm with the FITBONE1 SAA nail.
With a consolidation index of 35.2 days/cm, the Albizzia1
nail appears faster [14]. The consolidation index in the
ISKD1 ranged from 21 to 29 days/cm [21, 27]. In our
group with the FITBONE1 TAA, the consolidation index
was 26 days/cm.
The short time of an average of 9.6 days of hospital-
ization and the fast rehabilitation of our patients are
important aspects in favor of the TAA [3, 19, 37]. Without
transfixation of skin and muscles, the TAA facilitates
physiotherapy before and during the distraction phase. We
required early postoperative mobilization and partial
weightbearing, which were possible for our patients. After
3 to 4 weeks in the consolidation phase, the patients
returned to full weightbearing. Many patients who were
treated with an external fixator often reported discomfort
caused by pin cleaning, serious sleeping problems, clothing
restrictions, painful soft tissue transfixation and conse-
quently decreased joint mobility, and the overall long
disability caused by external fixation accompanied
by delayed return to normal daily activities and work [22,
32, 41].
Our initial experiences with the FITBONE1 TAA in
this group of adolescent patients suggest some patients
could benefit from its use. In comparison to external
fixators, its advantages are simple handling, the pro-
grammable motor with exact control, early full
weightbearing, faster rehabilitation, and excellent func-
tional results already present during the consolidation
phase. Potential advantages of intramedullary lengthening
devices include the reduced risk of contractures and
infections, better maintenance of axis correction, a lower
rate of refractures, reduction of pain resulting from the
elimination of soft tissue transfixation, and an earlier
return to daily activities.
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